Long-term follow-up of patients with chronic myeloid leukemia having received autologous stem cell transplantation

Annals of Hematology

Volumn 90, Issue 4, 2011, Pages 395-399

  Hackanson, Björn ^a   Waller, Cornelius F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Autologous transplantation; CML; Long term follow up

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DASATINIB; ETOPOSIDE; IDARUBICIN; IMATINIB; NILOTINIB; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA REMISSION; LONG TERM CARE; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT RESPONSE; AUTOTRANSPLANTATION; DISEASE COURSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; REMISSION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; REMISSION INDUCTION; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 79955938721     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1094-y     Document Type: Article

References (22)

1. Koeffler HP, Golde DW (1981) Chronic myelogenous leukemia- new concepts. N Engl J Med 304:1201-1209
2. Daley GQ, Van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 16(247):824-830
3. Sawyers CL (1999) Chronic myeloid leukemia. N Engl J Med 340:1330-1340
4. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561-566
5. Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J et al (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27:6041-6051
6. Peggs K, Mackinnon S (2003) Imatinib mesylate-the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med 348:1048-1050 (Pubitemid 36302251)
7. Hochhaus A, O'Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L et al (2009) Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 23:1054-1061
8. McGlave PB, De Fabritiis P, Deisseroth A, Goldman J, Barnett M, Reiffers J et al (1994) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. Lancet 343:1486-1488 (Pubitemid 24176342)
9. Bhatia R, Verfaillie CM, Miller JS, McGlave PB (1997) Autologous transplantation therapy for chronic myelogenous leukemia. Blood 89:2623-2634 (Pubitemid 27172546)
10. Waller CF, Heinzinger M, Rosenstiel A, Lange W (1998) Mobilization and transplantation of Philadelphia chromosomenegative peripheral blood progenitor cells in patients with CML. Br J Haematol 103:227-234 (Pubitemid 28470824)
11. Heinzinger M, Waller CF, Rosenstiel A, Scheid S, Burger KJ, Lange W (1998) Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML. Leukemia 12:333-339 (Pubitemid 28138217)
12. Bergamaschi G, Podestà M, Frassoni F, Rosti V, Carella AM, Saglio G et al (1994) Restoration of normal polyclonal haemopoiesis in patients with chronic myeloid leukaemia autografted with Ph-negative peripheral stem cells. Br J Haematol 87:867-870 (Pubitemid 24264667)
13. Carella AM, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podestà M et al (1997) Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol 15:1575-1582 (Pubitemid 27167395)
14. Carella AM, Beltrami G, Corsetti MT (2003) Autografting in chronic myeloid leukemia. Semin Hematol 40:72-78 (Pubitemid 36160111)
15. CML Autograft Trials Collaboration (2007) Autologous stem cell transplantation in chronic myeloid leukaemia: a meta-analysis of six randomized trials. Cancer Treat Rev 33:39-47
16. Olavarria E (2007) Autologous stem cell transplantation in chronic myeloid leukemia. Semin Hematol 44:252-258
17. Perseghin P, Gambacorti-Passerini C, Tornaghi L, Dassi M, Pioltelli P, Parma M et al (2005) Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate. Transfusion 45:1214-1220 (Pubitemid 40935023)
18. Simonsson B, Oberg G, Bjoreman M, Bjorkholm M, Carneskog J, Karlsson K et al (2005) Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up. Acta Haematol 113:155-162 (Pubitemid 40663265)
19. Kreuzer KA, Klühs C, Baskaynak G, Movassaghi K, Dörken B, le Coutre P (2004) Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging. Br J Haematol 124:195-199 (Pubitemid 38122192)
20. Hui CH, Goh KY, White D, Branford S, Grigg A, Seymour JF et al (2003) Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR. Leukemia 17:821-828 (Pubitemid 36626306)
21. le Coutre P, Kreuzer KA,Massenkeil G, Baskaynak G, Zschieschang P, Genvresse I et al (2003) Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML. Leukemia 17:2525-2526 (Pubitemid 38072594)
22. Fischer T, Reifenrath C, Hess GR, Corsetti MT, Kreil S, Beck J et al (2002) Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT). Leukemia 16:1220-1228